AAAAAA

   
Results: 1-13 |
Results: 13
EXPLORING AND EXPLOITING THE ANTIBODY AND IG SUPERFAMILY COMBINING SITES
Authors: GEORGE A HUSTON JS HABER E
Citation: A. George et al., EXPLORING AND EXPLOITING THE ANTIBODY AND IG SUPERFAMILY COMBINING SITES, Nature biotechnology, 14(5), 1996, pp. 584-584
RADIOMETAL LABELING OF RECOMBINANT PROTEINS BY A GENETICALLY-ENGINEERED MINIMAL CHELATION SITE - TC-99M COORDINATION BY SINGLE-CHAIN FV ANTIBODY FUSION PROTEINS THROUGH A C-TERMINAL CYSTEINYL PEPTIDE (VOL 92, PG 8358, 1995)
Authors: GEORGE AJT JAMAR F TAI MS HEELAN BT ADAMS GP MCCARTNEY JE HOUSTON LL WEINER LM OPPERMANN H PETERS AM HUSTON JS
Citation: Ajt. George et al., RADIOMETAL LABELING OF RECOMBINANT PROTEINS BY A GENETICALLY-ENGINEERED MINIMAL CHELATION SITE - TC-99M COORDINATION BY SINGLE-CHAIN FV ANTIBODY FUSION PROTEINS THROUGH A C-TERMINAL CYSTEINYL PEPTIDE (VOL 92, PG 8358, 1995), Proceedings of the National Academy of Sciences of the United Statesof America, 93(18), 1996, pp. 9991-9991
SYMMETRY OF FV ARCHITECTURE IS CONDUCIVE TO GRAFTING A 2ND ANTIBODY-BINDING SITE IN THE FV REGION
Authors: KECK PC HUSTON JS
Citation: Pc. Keck et Js. Huston, SYMMETRY OF FV ARCHITECTURE IS CONDUCIVE TO GRAFTING A 2ND ANTIBODY-BINDING SITE IN THE FV REGION, Biophysical journal, 71(4), 1996, pp. 2002-2011
OPTIMIZATION OF IN-VIVO TUMOR TARGETING IN SCID MICE WITH DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV - EFFECTS OF DOSE-ESCALATION AND REPEATED IV ADMINISTRATION
Authors: ADAMS GP MCCARTNEY JE WOLF EJ EISENBERG J TAI MS HUSTON JS STAFFORD WF BOOKMAN MA HOUSTON LL WEINER LM
Citation: Gp. Adams et al., OPTIMIZATION OF IN-VIVO TUMOR TARGETING IN SCID MICE WITH DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV - EFFECTS OF DOSE-ESCALATION AND REPEATED IV ADMINISTRATION, Cancer immunology and immunotherapy, 40(5), 1995, pp. 299-306
ENGINEERING DISULFIDE-LINKED SINGLE-CHAIN FV DIMERS [(SFV')(2)] WITH IMPROVED SOLUTION AND TARGETING PROPERTIES - ANTIDIGOXIN-26-10 (SFV')(2) AND ANTI-C-ERBB-2 741F8 (SFV')(2) MADE BY PROTEIN-FOLDING AND BONDED THROUGH C-TERMINAL CYSTEINYL PEPTIDES
Authors: MCCARTNEY JE TAI MS HUDZIAK RM ADAMS GP WEINER LM JIN D STAFFORD WF LIU S BOOKMAN MA LAMINET AA FAND I HOUSTON LL OPPERMANN H HUSTON JS
Citation: Je. Mccartney et al., ENGINEERING DISULFIDE-LINKED SINGLE-CHAIN FV DIMERS [(SFV')(2)] WITH IMPROVED SOLUTION AND TARGETING PROPERTIES - ANTIDIGOXIN-26-10 (SFV')(2) AND ANTI-C-ERBB-2 741F8 (SFV')(2) MADE BY PROTEIN-FOLDING AND BONDED THROUGH C-TERMINAL CYSTEINYL PEPTIDES, Protein engineering, 8(3), 1995, pp. 301-314
ENHANCED TUMOR SPECIFICITY OF 741F8-1(SFV')(2), AN ANTI-C-ERBB-2 SINGLE-CHAIN FV DIMER, MEDIATED BY STABLE RADIOIODINE CONJUGATION
Authors: ADAMS GP MCCARTNEY JE WOLF EJ EISENBERG J HUSTON JS BOOKMAN MA MOLDOFSKY P STAFFORD WF HOUSTON LL WEINER LM
Citation: Gp. Adams et al., ENHANCED TUMOR SPECIFICITY OF 741F8-1(SFV')(2), AN ANTI-C-ERBB-2 SINGLE-CHAIN FV DIMER, MEDIATED BY STABLE RADIOIODINE CONJUGATION, The Journal of nuclear medicine, 36(12), 1995, pp. 2276-2281
RADIOMETAL LABELING OF RECOMBINANT PROTEINS BY A GENETICALLY-ENGINEERED MINIMAL CHELATION SITE - TC-99M COORDINATION BY SINGLE-CHAIN FV ANTIBODY FUSION PROTEINS THROUGH A C-TERMINAL CYSTEINYL PEPTIDE
Authors: GEORGE AJT JAMAR F TAI MS HEELAN BT ADAMS GP MCCARTNEY JE HOUSTON LL WEINER LM OPPERMANN H PETERS AM HUSTON JS
Citation: Ajt. George et al., RADIOMETAL LABELING OF RECOMBINANT PROTEINS BY A GENETICALLY-ENGINEERED MINIMAL CHELATION SITE - TC-99M COORDINATION BY SINGLE-CHAIN FV ANTIBODY FUSION PROTEINS THROUGH A C-TERMINAL CYSTEINYL PEPTIDE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(18), 1995, pp. 8358-8362
TARGETING C-ERBB-2 EXPRESSING TUMORS USING SINGLE-CHAIN FV MONOMERS AND DIMERS
Authors: TAI MS MCCARTNEY JE ADAMS GP JIN D HUDZIAK RM OPPERMANN H LAMINET AA BOOKMAN MA WOLF EJ LIU S STAFFORD WF FAND I HOUSTON LL WEINER LM HUSTON JS
Citation: Ms. Tai et al., TARGETING C-ERBB-2 EXPRESSING TUMORS USING SINGLE-CHAIN FV MONOMERS AND DIMERS, Cancer research, 55(23), 1995, pp. 5983-5989
MAMMALIAN-CELL EXPRESSION OF SINGLE-CHAIN FV (SFV) ANTIBODY PROTEINS AND THEIR C-TERMINAL FUSIONS WITH INTERLEUKIN-2 AND OTHER EFFECTOR DOMAINS
Authors: DORAI H MCCARTNEY JE HUDZIAK RM TAI MS LAMINET AA HOUSTON LL HUSTON JS OPPERMANN H
Citation: H. Dorai et al., MAMMALIAN-CELL EXPRESSION OF SINGLE-CHAIN FV (SFV) ANTIBODY PROTEINS AND THEIR C-TERMINAL FUSIONS WITH INTERLEUKIN-2 AND OTHER EFFECTOR DOMAINS, Bio/technology, 12(9), 1994, pp. 890-897
REDIRECTION OF T-CELL-MEDIATED CYTOTOXICITY BY A RECOMBINANT SINGLE-CHAIN FV MOLECULE
Authors: GEORGE AJT TITUS JA JOST CR KURUCZ I PEREZ P ANDREW SM NICHOLLS PJ HUSTON JS SEGAL DM
Citation: Ajt. George et al., REDIRECTION OF T-CELL-MEDIATED CYTOTOXICITY BY A RECOMBINANT SINGLE-CHAIN FV MOLECULE, The Journal of immunology, 152(4), 1994, pp. 1802-1811
CHIMERIC BISPECIFIC ANTIBODY-BINDING SITES (CHI-BABS) - DESIGN OF A 2ND COMBINING SITE WITHIN THE FV REGION AND RECOVERY OF SINGLE-CHAIN FVBINDING-ACTIVITY AFTER INTEGRATION OF NEW BINDING LOOPS BETWEEN BETA-STRANDS OF V-DOMAINS
Authors: KECK PC TAI MS OPPERMANN H HUSTON JS
Citation: Pc. Keck et al., CHIMERIC BISPECIFIC ANTIBODY-BINDING SITES (CHI-BABS) - DESIGN OF A 2ND COMBINING SITE WITHIN THE FV REGION AND RECOVERY OF SINGLE-CHAIN FVBINDING-ACTIVITY AFTER INTEGRATION OF NEW BINDING LOOPS BETWEEN BETA-STRANDS OF V-DOMAINS, Biophysical journal, 66(2), 1994, pp. 10000341-10000341
INVIVO TUMOR SPECIFICITY OF MONOMERIC AND DIMERIC FORMS OF THE 25 KD ANTI-C-ERBB-2 SINGLE-CHAIN FV (SFV) MOLECULE, 741F8
Authors: ADAMS GP HUSTON JS HOUSTON LL FAND I BOOKMAN MA WEINER LM
Citation: Gp. Adams et al., INVIVO TUMOR SPECIFICITY OF MONOMERIC AND DIMERIC FORMS OF THE 25 KD ANTI-C-ERBB-2 SINGLE-CHAIN FV (SFV) MOLECULE, 741F8, The Journal of immunology, 150(8), 1993, pp. 142-142
HIGHLY SPECIFIC IN-VIVO TUMOR TARGETING BY MONOVALENT AND DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV
Authors: ADAMS GP MCCARTNEY JE TAI MS OPPERMANN H HUSTON JS STAFFORD WF BOOKMAN MA FAND I HOUSTON LL WEINER LM
Citation: Gp. Adams et al., HIGHLY SPECIFIC IN-VIVO TUMOR TARGETING BY MONOVALENT AND DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV, Cancer research, 53(17), 1993, pp. 4026-4034
Risultati: 1-13 |